Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Bibliographic Data
| ID | 15526141 |
|---|---|
| Authors | Jian-Qiang Tan (Jiangmen Central Hospital), Li-Mei Gu (Guangzhou Medical University), Yanling Zhou (0000-0002-3966-4424, Guangzhou Medical University), Yan-Ling Zhou, Chengyu Wang (0000-0003-0516-332X, Guangzhou Medical University), Cheng-yu Wang, Xiaofeng Lan (0000-0002-7042-084X, Guangzhou Medical University), Xiao-Feng Lan, Wei Zheng (0000-0002-3339-5606, Guangzhou Medical University, corresponding author), Yuping Ning (0000-0002-5727-2782, Southern Medical University, corresponding author), Yu-Ping Ning |
| Year | 2025 |
| Volume | 16 |
| Pages | 1498952-1498952 |
| Publication date | 2025-02-18 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2025.1498952 |
| PMID | 40041696 |
| OpenAlex | W4407716235 |
| Language | EN |
| References cited | 56 |
Our exploratory, post-hoc analysis of an open-label, single-arm study suggests that patients with depression and a higher baseline BMI may experience greater reductions in depressive symptoms compared with those with a lower baseline BMI after receiving six ketamine infusions
Anesthesia · Antidepressant · Anxiety · Body mass index · Depression (economics · Ketamine · Major depressive disorder · Mood · Psychiatry · Diet and metabolism studies · Medicine · Psychology · Treatment of Major Depression · Tryptophan and brain disorders · Internal Medicine
| Highly cited | No |
|---|